Professional Documents
Culture Documents
Pulmonary aspergillosis
M.L. Chabi a,∗, A. Goracci b, N. Roche c, A. Paugam d,
A. Lupo e, M.P. Revel f
a
Service de radiologie polyvalente et oncologique, groupe hospitalier de la Pitié-Salpêtrière
— Charles-Foix, AP—HP, 83, boulevard de l’Hôpital, 75651 Paris cedex 13, France
b
Département d’imagerie médicale, service de radiologie, IRCCS Istituto Clinico Humanitas,
Via Manzoni 56, 20089 Rozzano, Italy
c
Service de pneumologie, hôpital d’instruction des armées du Val-de-Grâce, 74, boulevard de
Port-Royal, 75230 Paris cedex 05, France
d
Service de parasitologie-mycologie-médecine tropicale, hôpital Cochin, 27, rue du
Faubourg-Saint-Jacques, 75679 Paris cedex 14, France
e
Service d’anatomie et de cytologie pathologiques, hôpital Cochin, 27, rue du
Faubourg-Saint-Jacques, 75679 Paris cedex 14, France
f
Service de radiologie A, hôpital Cochin, 27, rue du Faubourg-Saint-Jacques, 75679 Paris
cedex 14, France
KEYWORDS Abstract Aspergillosis is a mycotic disease usually caused by Aspergillus fumigatus, a sapro-
Aspergillosis; phytic and ubiquitous airborne fungus. Aspergillus-related lung diseases are traditionally
Lung infections; classified into four different forms, whose occurrence depends on the immunologic status of the
Computed host and the existence of an underlying lung disease. Allergic broncho-pulmonary aspergillo-
tomography sis (ABPA) affects patients with asthma or cystic fibrosis. Saprophytic infection (aspergilloma)
occurs in patients with abnormal airways (chronic obstructive pulmonary disease, bronchiec-
tasis, cystic fibrosis) or chronic lung cavities. Chronic necrotizing aspergillosis (semi-invasive
form) is described in patients with chronic lung pathology or mild immunodeficiency. Invasive
aspergillosis (angio-invasive or broncho-invasive forms) occurs in severely immuno-compromised
patients. Knowledge of the various radiological patterns for each form, as well as the corre-
sponding associated immune disorders and/or underlying lung diseases, helps early recognition
and accurate diagnosis.
© 2015 Éditions françaises de radiologie. Published by Elsevier Masson SAS. All rights reserved.
Abbreviations: A. fumigatus, Aspergillus fumigatus; ABPA, allergic broncho-pulmonary aspergillosis; COPD, chronic obstructive pul-
monary disease; CF, cystic fibrosis; HRCT, high-resolution computed tomography; CAN, chronic necrotizing aspergillosis; BAL, bronchoalveolar
lavage.
∗ Corresponding author.
Figure 1. A 30-year-old asthmatic man with productive cough and dyspnea. Axial (a) and coronal (b, c) CT images show bilateral subseg-
mental bronchectasis filled with mucus (arrows). These images are called finger-in-glove opacities and are consistent with ABPA diagnosis.
On mediastinal windowing (d), mucus plugs are hyperdense (102 HU); e: coronal CT image after treatment. Mucus plugging has disappeared
whereas bronchectasis persist (head arrow).
Figure 3. Coronal (a) and sagittal (b) CT images showing pathognomonic aspergilloma: mass within a lung cavity surrounded by air, which
is called the ‘‘air crescent’’ sign. Aspergilloma cannot be diagnosed on chest X ray (c), because the air crescent sign is not visible.
Figure 4. a: tuberculosis sequelae in pulmonary apices on chest X ray; b and c: CT images demonstrate a fungus ball within a pulmonary
cavity in the left lower lung apex, which is pathognomonic for aspergilloma. Chest X ray only demonstrates bilateral opacities with retraction
of both lung apices.
Figure 5. a: axial CT image showing a broncho-pleural fistula complicating left upper lobe resection; b: CT scan performed 1 year later
shows thickening of the cavity walls; c: two years later, a fungus ball with ‘‘air crescent’’ sign is demonstrated. All chronic lung cavities can
be colonized by Aspergillus and develop aspergilloma. The first sign of the saprophytic infection is usually a thickening of the cavity walls.
the main complication. Aspergillomas remain stable in the Chronic necrotizing aspergillosis (former
majority of cases, but can also decrease in size or even spon- semi-invasive form)
taneously resolve in about 10% of cases. Aspergillomas more
rarely show size increase [10]. Chronic necrotizing aspergillosis (CNA) is a rare and
Other causes of ‘‘air crescent’’ sign include angio- poorly understood form of aspergillosis, which can
invasive and chronic necrotizing aspergillosis. In these cases, mimic other chronic pulmonary infections (tuberculosis,
there are no pre-existing cavities; radiological manifesta- histoplasmosis. . .). Its recognition and diagnosis are often
tions appear within a few days in the angio-invasive forms delayed.
and within several weeks or months in the chronic necrotiz- CNA is a locally invasive disease that occurs in patients
ing forms [11] (Fig. 6). with chronic lung pathology [12] or mild immunodeficiency
Pulmonary aspergillosis 439
Figure 6. ‘‘Air crescent’’ sign. Axial CT images of 3 different patients, showing a lung parenchyma opacity surrounded by an ‘‘air crescent’’
sign. This feature is not specific of saprophytic infection (aspergilloma; a), it can be seen in semi-invasive aspergillosis (chronic necrotizing
aspergillosis; b) and in invasive aspergillosis (c). In the latter two cases (b and c), there was not any pre-existing lung cavity; the focal area
of necrosis is due to fungal invasion.
such as long-standing steroid therapy, diabetes, renal fail- Invasive aspergillosis: angio-invasive and
ure, COPD. . . airway-invasive forms
Radiologically, CNA is characterized by pulmonary
consolidations, usually involving the upper lobes, with Invasive pulmonary aspergillosis is an aggressive disease due
bronchiectasis. The consolidation progresses with time to to the invasion of the bronchial wall and the accompany-
cavitation over weeks to months [12,13]. ing arterioles by the hyphae. This form primarily occurs in
As indicated earlier, a ‘‘fungal ball’’ with ‘‘air crescent severely immuno-compromised patients, especially patients
sign’’ may develop in CNA as a secondary phenomenon due with neutropenia due to allogenic bone marrow transplan-
to the parenchymal destruction by the fungus [11] (Fig. 7). tation or chemotherapy for acute leukemia [15], but also
In 2003, Denning et al. proposed diagnostic criteria for patients who received solid-organ transplantation, espe-
CNA [14] (Boxed text). cially lung transplantation [16].
The most important risk factor is neutropenia. The risk of
invasive aspergillosis is strongly correlated with the duration
and degree of neutropenia [11].
Symptoms are non-specific and usually mimic bron-
Boxed text: Denning’s criteria [14] for chronic
chopneumonia, but also include pleuritic chest pain and
necrotizing aspergillosis.
• Chronic pulmonary or systemic symptoms (duration haemoptysis [11].
Invasive aspergillosis is a diagnostic and therapeutic chal-
3 months) compatible with CPA, including at least 1
lenge due to the high morbidity and mortality.
of the following symptoms: weight loss, productive
There are two sub-categories of invasive aspergillosis,
cough, or haemoptysis.
• Cavitary pulmonary lesion with evidence of the airway-invasive form and the angio-invasive form.
The airway-invasive form accounts for 15 to 30% of
paracavitary infiltrates, new cavity formation,
invasive aspergillosis, and is defined by the presence of
or expansion of cavity size over time.
• Either positive result of serum Aspergillus precipitins Aspergillus deep to the basal membrane of the bronchi [17].
Radiologically, it can mimic bronchiolitis with patchy cen-
test or isolation of Aspergillus spp. from pulmonary
trilobular nodules with tree-in-bud appearance, similar to
or pleural cavity.
• Elevated levels of inflammatory markers (C- those seen in endobronchial spread of tuberculosis. A bron-
chopneumonia presentation is common, with confluence of
reactive protein, plasma viscosity, or erythrocyte
peribronchial consolidations, similar to bacterial bronchop-
sedimentation rate).
• Exclusion of other pulmonary pathogens, by results neumonia [8,17] (Fig. 8).
In rare cases, the fungal infection is entirely or pre-
of appropriate cultures and serological tests, that
dominantly confined to the tracheobronchial tree. Acute
are associated with similar disease presentation,
Aspergillus tracheobronchitis usually occurs in lung trans-
including mycobacteria and endemic fungi
plantation recipients [16]. Radiologically, it may appear as
(especially Coccidioides immitis and Histoplasma
tracheal or bronchial irregular wall thickening, with occa-
capsulatum).
• No overt immunocompromising conditions (e.g., sionally high attenuation aspect due to ability of Aspergillus
to fix calcium. Atelectasis or endobronchial masses have
HIV infection, leukemia, and chronic granulomatous
even been described. However, most of the time, there are
disease).
no detectable radiological abnormalities [8,18].
440 M.L. Chabi et al.
Figure 7. Chronic necrotizing aspergillosis; a and b: axial CT images showing a right upper lobe consolidation with bronchectasis; c and
d: correspond to CT images of the same patient 5 months (c) and 7 months (d) latter. Progressive cavitation of the initial consolidation is
seen; e and f: are chest radiographs corresponding to CT scans images c and d. They show a progressive cavitation of the right upper lobe.
Comparison with the first available chest X ray is crucial, to detect the progressive cavitation because changes occur slowly, which is the
source of delayed diagnosis.
The angio-invasive form is histologically characterized consolidation, similar to those seen in pulmonary infarcts
by the invasion and occlusion of small to medium-size complicating pulmonary embolism, correspond to haemor-
pulmonary arteries by fungal hyphae [8]. Typical CT find- rhagic infarcts.
ings [8,17] consist in larges nodules surrounded by ground Differential diagnoses of ‘‘halo sign’’ in neu-
glass attenuation, which is called the ‘‘halo sign’’. Nod- tropenic patients include infections due to Candida,
ules are due to coagulation necrosis, whereas the halo Herpes simplex and cytomegalovirus, Wegener gran-
of ground glass is due to surrounding alveolar haemorr- ulomatosis, haemorrhagic metastases and Kaposi
hage [19] (Fig. 9). Other findings are pleura-based areas of sarcoma.
Figure 8. Broncho-invasive aspergillosis in a 50-year-old man with allogenic bone marrow transplantation. Axial CT images (a, b) showing
bilateral lobular consolidation with centrilobular nodules in the left lower lobe (b). These features are non-specific of fungal infection and
could also be due to bacterial bronchopneumonia.
Pulmonary aspergillosis 441
Figure 10. a: axial CT image in a leukemia patient showing a right upper lobe nodule surrounded by mild ground glass attenuation; b and
c: axial and coronal CT images acquired 3 weeks later showing an ‘‘air crescent’’ sign surrounding a focal opacity. This feature is similar to
aspergilloma but is relevant to a necrotic lung fragment in an angio-invasive form of aspergillosis.
442 M.L. Chabi et al.
Further, as for serum, Aspergillus antigens (galactoman- fibrosis — state of the art: Cystic Fibrosis Foundation Consensus
nan) and A. fumigatus DNA (by PCR) can be detected in BAL Conference. Clin Infect Dis 2003;37(Suppl. 3):S225—64.
[21]. [7] Knutsen AP, Slavin RG. Allergic bronchopulmonary aspergillo-
sis in asthma and cystic fibrosis. Clin Dev Immunol
Biopsy 2011;2011:843763.
[8] Franquet T, Muller NL, Gimenez A, Guembe P, de La Torre
J, Bague S. Spectrum of pulmonary aspergillosis: histologic,
The histopathological examination of lung tissue with posi-
clinical, and radiologic findings. Radiographics 2001;21(4):
tive culture is the gold standard for the diagnosis of invasive 825—37.
aspergillosis [11]. Nevertheless, surgical biopsies are infre- [9] Glimp RA, Bayer AS. Pulmonary aspergilloma. Diagnos-
quently performed, only for diagnosis purposes in fragile tic and therapeutic considerations. Arch Intern Med
patients. 1983;143(2):303—8.
[10] Gefter WB. The spectrum of pulmonary aspergillosis. J Thorac
Imaging 1992;7(4):56—74.
Conclusion [11] Kousha M, Tadi R, Soubani AO. Pulmonary aspergillosis: a clin-
ical review. Eur Respir Rev 2011;20(121):156—74.
The spectrum of respiratory diseases caused by Aspergillus [12] Franquet T, Muller NL, Gimenez A, Domingo P, Plaza V, Bordes
is wide. It includes hypersensitivity in ABPA, saprophytic R. Semiinvasive pulmonary aspergillosis in chronic obstructive
pulmonary disease: radiologic and pathologic findings in nine
infection in pre-existing broncho-pulmonary diseases and
patients. AJR Am J Roentgenol 2000;174(1):51—6.
semi-invasive or invasive forms in immuno-compromised [13] Kim SY, Lee KS, Han J, Kim J, Kim TS, Choo SW, et al. Semi-
patients. invasive pulmonary aspergillosis: CT and pathologic findings in
The correlation between the immunologic status of the six patients. AJR Am J Roentgenol 2000;174(3):795—8.
host, an essential factor in the occurrence of Aspergillus- [14] Denning DW, Riniotis K, Dobrashian R, Sambatakou H. Chronic
related lung diseases, and the radiological presentation is of cavitary and fibrosing pulmonary and pleural aspergillosis: case
major importance for accurate diagnosis of these diseases. series, proposed nomenclature change, and review. Clin Infect
Dis 2003;37(Suppl. 3):S265—80.
[15] Bommart S, Bourdin A, Makinson A, Durand G, Micheau
Disclosure of interest A, Monnin-Bares V, et al. Infectious chest complications
in haematological malignancies. Diagn Interv Imaging
2013;94(2):193—201.
The authors declare that they have no conflicts of interest
[16] Hemmert C, Ohana M, Jeung MY, Labani A, Dhar A, Kessler R,
concerning this article. et al. Imaging of lung transplant complications. Diagn Interv
Imaging 2014;95(4):399—409.
[17] Logan PM, Primack SL, Miller RR, Muller NL. Invasive aspergillo-
References sis of the airways: radiographic, CT, and pathologic findings.
Radiology 1994;193(2):383—8.
[1] Latge JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol [18] Fernandez-Ruiz M, Silva JT, San-Juan R, de Dios B, Garcia-
Rev 1999;12(2):310—50. Lujan R, Lopez-Medrano F, et al. Aspergillus tracheobronchitis:
[2] Mandeel QA. Fungal contamination of some imported spices. report of 8 cases and review of the literature. Medicine
Mycopathologia 2005;159(2):291—8. 2012;91(5):261—73.
[3] Kagen SL. Aspergillus: an inhalable contaminant of marihuana. [19] Greene RE, Schlamm HT, Oestmann JW, Stark P, Durand C,
N Engl J Med 1981;304(8):483—4. Lortholary O, et al. Imaging findings in acute invasive pul-
[4] Agarwal R. Allergic bronchopulmonary aspergillosis. Chest monary aspergillosis: clinical significance of the halo sign. Clin
2009;135(3):805—26. Infect Dis 2007;44(3):373—9.
[5] Agarwal R, Chakrabarti A, Shah A, Gupta D, Meis JF, Guleria R, [20] Buckingham SJ, Hansell DM. Aspergillus in the lung: diverse and
et al. Allergic bronchopulmonary aspergillosis: review of litera- coincident forms. Eur Radiol 2003;13(8):1786—800.
ture and proposal of new diagnostic and classification criteria. [21] Reichenberger F, Habicht JM, Gratwohl A, Tamm M. Diagnosis
Clin Exp Allergy 2013;43(8):850—73. and treatment of invasive pulmonary aspergillosis in neu-
[6] Stevens DA, Moss RB, Kurup VP, Knutsen AP, Greenberger P, Jud- tropenic patients. Eur Respir J 2002;19(4):743—55.
son MA, et al. Allergic bronchopulmonary aspergillosis in cystic